Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kerr

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
Plos One|February 18, 2026
Optimising delivery of integrated palliative care and heart failure services: A realist evaluation protocol (PalliatHeartSynthesis II)Tracey McConnell, David Scott, Geoffrey Wong, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
Heart (British Cardiac Society)|July 3, 2024
Treatment drop-in in a contemporary cohort used to derive cardiovascular risk prediction equationsJingyuan Liang, Rodney T Jackson, Romana Pylypchuk, et al.
European Journal of Preventive Cardiology|September 28, 2023
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular diseaseAnders Holt, Bruno Batinica, Jingyuan Liang, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
The New Zealand Medical Journal|July 12, 2019
Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29)Andrew Kerr, Mildred Lee, Corina Grey, et al.
Journal of the American Society for Mass Spectrometry|July 15, 2021
Characterization Across a Dispersity: Polymer Mass Spectrometry in the Second DimensionTomos E Morgan, Christopher A Wootton, Bryan Marzullo, et al.
Trials|January 27, 2018
Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trialRalph Maddison, Ralph Stewart, Rob Doughty, et al.
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
The New Zealand Medical Journal|August 11, 2016
The All New Zealand Acute Coronary Syndrome Quality Improvement Programme: Implementation, Methodology and Cohorts (ANZACS-QI 9)Andrew Kerr, Michael Ja Williams, Harvey White, et al.
Plos One|February 18, 2026
Optimising delivery of integrated palliative care and heart failure services: A realist evaluation protocol (PalliatHeartSynthesis II)Tracey McConnell, David Scott, Geoffrey Wong, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
Heart (British Cardiac Society)|July 3, 2024
Treatment drop-in in a contemporary cohort used to derive cardiovascular risk prediction equationsJingyuan Liang, Rodney T Jackson, Romana Pylypchuk, et al.
European Journal of Preventive Cardiology|September 28, 2023
Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular diseaseAnders Holt, Bruno Batinica, Jingyuan Liang, et al.
Lancet (London, England)|May 9, 2018
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation studyRomana Pylypchuk, Sue Wells, Andrew Kerr, et al.
The New Zealand Medical Journal|July 12, 2019
Acute reperfusion for ST-elevation myocardial infarction in New Zealand (2015-2017): patient and system delay (ANZACS-QI 29)Andrew Kerr, Mildred Lee, Corina Grey, et al.
Journal of the American Society for Mass Spectrometry|July 15, 2021
Characterization Across a Dispersity: Polymer Mass Spectrometry in the Second DimensionTomos E Morgan, Christopher A Wootton, Bryan Marzullo, et al.
Trials|January 27, 2018
Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trialRalph Maddison, Ralph Stewart, Rob Doughty, et al.
Journal of Primary Health Care|June 1, 2011
Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15)Suneela Mehta, Sue Wells, Tania Riddell, et al.
Pageof 14